Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Andermatt Biocontrol is a global leader in the development, production, and distribution of biological plant protection solutions. Founded in 1988 and headquartered in Switzerland, the company specializes in baculoviruses, microbial products, beneficial insects, and pheromones as sustainable alternatives to chemical pesticides. Their portfolio serves organic and integrated pest management (IPM) systems across agriculture, horticulture, and forestry. Andermatt operates a vast network of subsidiaries and distribution partners worldwide, maintaining a strong focus on innovation in microbial fermentation and formulation. The company is recognized as a pioneer in the commercialization of granulovirus-based biopesticides.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Andermatt Biocontrol.